Bio-Techne Corporation (TECH) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Minneapolis, MN, United States. The current CEO is Kim Kelderman.
TECH has IPO date of 1989-02-09, 3,100 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $9.18B.
Bio-Techne Corporation is a life sciences company that develops, manufactures, and sells reagents, instruments, and diagnostic services for research and clinical markets globally. Operating through two main segments—Protein Sciences and Diagnostics and Genomics—the company offers a comprehensive portfolio including biological reagents, antibodies, cytokines, proteomic analytical tools, and diagnostic assays for oncology, genetic screening, and molecular diagnostics. Its products serve cell and gene therapy, tissue analysis, and hematology applications under recognized brands including R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, and Asuragen. Founded in 1976 and headquartered in Minneapolis, Minnesota, Bio-Techne has established itself as a trusted supplier to academic institutions, pharmaceutical companies, clinical laboratories, and diagnostic centers worldwide.
